Showing results (711-720 of 977) with videos related to
Sort By:
Pageof 98
Journal of Neuro-Oncology|January 20, 2017
Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trialsAndreas Merkel, Dorothea Soeldner, Christina Wendl, et al.American Journal of Nephrology|June 2, 2007
Cigarette smoking and incident chronic kidney disease: a systematic reviewCharlotte Jones-Burton, Stephen L Seliger, Roberta W Scherer, et al.International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.Journal of the American Geriatrics Society|January 14, 2026
The Role of Brain Structure in Explaining Physical Functioning in Male Veterans With Impaired Kidney FunctionJulie S Rekant, Hinza B Malik, Jamie E Giffuni, et al.Oncoimmunology|March 14, 2024
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAMLMarcus Bauer, Nadja Jäkel, Andreas Wilfer, et al.Human Genetics|June 1, 1996
Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGHH J Decker, C Neuhaus, A Jauch, et al.Proteomics|February 24, 2009
Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinomaBarbara Seliger, Sven P Dressler, Ena Wang, et al.European Journal of Cancer (Oxford, England : 1990)|June 18, 2017
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeLeisha A Emens, Paolo A Ascierto, Phillip K Darcy, et al.Kidney360|March 26, 2021
Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical TrialStephen L Seliger, Terry Watnick, Andrew D Althouse, et al.American Journal of Nephrology|January 8, 2026
Feasibility study of empagliflozin in patients with autosomal dominant polycystic kidney disease: Design and baseline characteristicsStephen L Seliger, Wei Wang, Terry Watnick, et al.Pageof 98